G. Öjteg

545 total citations
24 papers, 441 citations indexed

About

G. Öjteg is a scholar working on Nephrology, Molecular Biology and Surgery. According to data from OpenAlex, G. Öjteg has authored 24 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 5 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in G. Öjteg's work include Acute Kidney Injury Research (6 papers), Chronic Kidney Disease and Diabetes (3 papers) and Dialysis and Renal Disease Management (3 papers). G. Öjteg is often cited by papers focused on Acute Kidney Injury Research (6 papers), Chronic Kidney Disease and Diabetes (3 papers) and Dialysis and Renal Disease Management (3 papers). G. Öjteg collaborates with scholars based in Sweden, Bulgaria and Germany. G. Öjteg's co-authors include M. Wolgast, Örjan Källskog, Lars Karlberg, Bo Johan Norlén, Staffan Josephson, P. Hellberg, Kersti Hermansson, Alfred Bayati, Rikard Pehrson and Osamu Ishizuka and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Biochimica et Biophysica Acta (BBA) - General Subjects and American Journal of Physiology-Renal Physiology.

In The Last Decade

G. Öjteg

24 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Öjteg Sweden 12 164 102 77 71 55 24 441
Yoshihiro Takamitsu Japan 17 222 1.4× 177 1.7× 126 1.6× 103 1.5× 86 1.6× 64 792
H.-P. Leichtweiß Germany 11 117 0.7× 109 1.1× 86 1.1× 154 2.2× 67 1.2× 27 504
Akira Kato Japan 13 131 0.8× 176 1.7× 81 1.1× 29 0.4× 141 2.6× 32 617
R. Galaske Germany 13 195 1.2× 121 1.2× 70 0.9× 64 0.9× 64 1.2× 25 527
G. G. Pinter United States 13 85 0.5× 101 1.0× 54 0.7× 25 0.4× 60 1.1× 42 398
G. Peters Switzerland 12 77 0.5× 110 1.1× 89 1.2× 48 0.7× 52 0.9× 39 447
J. H. Cort Czechia 18 54 0.3× 150 1.5× 271 3.5× 28 0.4× 63 1.1× 38 677
P. M. Davies United Kingdom 11 98 0.6× 302 3.0× 34 0.4× 75 1.1× 36 0.7× 21 534
E. Bojesen Denmark 11 55 0.3× 172 1.7× 53 0.7× 53 0.7× 86 1.6× 20 483
N. Parekh Germany 12 129 0.8× 111 1.1× 88 1.1× 30 0.4× 173 3.1× 33 537

Countries citing papers authored by G. Öjteg

Since Specialization
Citations

This map shows the geographic impact of G. Öjteg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Öjteg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Öjteg more than expected).

Fields of papers citing papers by G. Öjteg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Öjteg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Öjteg. The network helps show where G. Öjteg may publish in the future.

Co-authorship network of co-authors of G. Öjteg

This figure shows the co-authorship network connecting the top 25 collaborators of G. Öjteg. A scholar is included among the top collaborators of G. Öjteg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Öjteg. G. Öjteg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoogstraate, Janet, L. Andersson, Odd‐Geir Berge, Bror Jonzon, & G. Öjteg. (2003). COX-inhibiting nitric oxide donators (CINODs) -- a new paradigm in the treatment of pain and inflammation. Inflammopharmacology. 11(4-6). 423–428. 16 indexed citations
2.
Sharma, Ravindra K., et al.. (2003). A cox‐inhibiting nitric oxide donator (CINOD): gastric tolerability profile in the rat. Clinical Pharmacology & Therapeutics. 73(2). 1 indexed citations
3.
Pehrson, Rikard, G. Öjteg, Osamu Ishizuka, & Karl‐Erik Andersson. (2002). Effects of NAD-299, a new, highly selective 5-HT 1A receptor antagonist, on bladder function in rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 366(6). 528–536. 21 indexed citations
4.
Öjteg, G.. (1998). The selective 5-HT1A receptor antagonist robalzotan: General pharmacodynamic effects. European Neuropsychopharmacology. 8. S145–S145. 1 indexed citations
5.
Öjteg, G., et al.. (1994). Renal handling and plasma elimination kinetics of carbonic anhydrase isoenzymes I, II and III in the rat. Acta Physiologica Scandinavica. 151(4). 531–539. 6 indexed citations
6.
Tunón, Håkan, Lars Bohlin, & G. Öjteg. (1994). The effect of Menyanthes trifoliata L. on acute renal failure might be due to PAF-inhibition. Phytomedicine. 1(1). 39–45. 11 indexed citations
7.
Öjteg, G. & M. Wolgast. (1993). Charge density of renal interstitium. Acta Physiologica Scandinavica. 147(3). 297–303. 1 indexed citations
8.
Wolgast, M., et al.. (1991). Oxygen radicals in postischaemic damages in the kidney. Journal of Molecular Medicine. 69(21-23). 1077–1082. 10 indexed citations
9.
Hellberg, P., Örjan Källskog, G. Öjteg, & M. Wolgast. (1990). Peritubular capillary permeability and intravascular RBC aggregation after ischemia: effects of neutrophils. American Journal of Physiology-Renal Physiology. 258(4). F1018–F1025. 52 indexed citations
10.
Öjteg, G., Per Lundahl, & M. Wolgast. (1989). The net electric charge of proteins. A comparison of determinations by Donnan potential measurements and by gel electrophoresis. Biochimica et Biophysica Acta (BBA) - General Subjects. 991(2). 317–323. 11 indexed citations
11.
Hellberg, P., Örjan Källskog, M. Wolgast, & G. Öjteg. (1988). Effects of neutrophil granulocytes on the inulin barrier of renal tubular epithelium after ischaemic damage. Acta Physiologica Scandinavica. 134(2). 313–315. 10 indexed citations
12.
Wolgast, M., Alfred Bayati, Olof Hellberg, Örjan Källskog, & G. Öjteg. (1988). Prevention of Acute Renal Failure by SOD and Sucrose. PubMed. 49. 1053–1056. 4 indexed citations
13.
Wolgast, M. & G. Öjteg. (1988). Electrophysiology of renal capillary membranes: gel concept applied and Starling model challenged. American Journal of Physiology-Renal Physiology. 254(3). F364–F373. 10 indexed citations
14.
Öjteg, G., Alfred Bayati, Örjan Källskog, & M. Wolgast. (1987). Renal capillary permeability and intravascular red cell aggregation after ischaemia. I. Effects of xanthine oxidase activity. Acta Physiologica Scandinavica. 129(3). 295–304. 27 indexed citations
15.
Öjteg, G., et al.. (1987). Permeability of renal capillaries. I. Preparation of neutral and charged protein probes. Acta Physiologica Scandinavica. 129(3). 277–286. 18 indexed citations
16.
Öjteg, G., et al.. (1987). Permeability of renal capillaries. II. Transport of neutral and charged protein molecular probes. Acta Physiologica Scandinavica. 129(3). 287–294. 9 indexed citations
17.
Hermansson, Kersti, G. Öjteg, & M. Wolgast. (1984). The cortical and medullary blood flow at different levels of renal nerve activity. Acta Physiologica Scandinavica. 120(2). 161–169. 29 indexed citations
18.
Karlberg, Lars, Bo Johan Norlén, G. Öjteg, & M. Wolgast. (1983). Impaired medullary circulation in postischemic acute renal failure. Acta Physiologica Scandinavica. 118(1). 11–17. 66 indexed citations
19.
Karlberg, Lars, Örjan Källskog, G. Öjteg, & M. Wolgast. (1982). Renal medullary blood flow studied with the 86‐Rb extraction method Methodological considerations. Acta Physiologica Scandinavica. 115(1). 11–18. 23 indexed citations
20.
Josephson, Staffan, M. Wolgast, & G. Öjteg. (1982). Experimental Obstructive Hydronephrosis in Newborn Rats. Scandinavian Journal of Urology and Nephrology. 16(2). 179–185. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026